Stocksigma LogoStocksigma Logo

Orchid Pharma Obtains Trading Approval for 4.46 Crore Amalgamation Shares

Orchid Pharma Limited received trading approval from the NSE and BSE for 4,45,86,052 equity shares, effective 23rd Sep'26

Orchid Pharma Obtains Trading Approval for 4.46 Crore Amalgamation Shares

Orchid Pharma Ltd 路 Others (Uncategorized) 路 24 Sept 2026, 1:30 am

Orchid Pharma Obtains Trading Approval for 4.46 Crore Amalgamation Shares Orchid Pharma Limited received trading approval from the NSE and BSE for 4,45,86,052 equity shares, effective 23rd Sep'26. These shares were previously allotted on 1st Aug'26 pursuant to an NCLT Chennai-approved Scheme of Amalgamation. With listing and trading formalities completed across both exchanges, the newly allotted shares are now fully admitted to dealings, expanding the company's freely tradable equity base.

Original exchange filing (PDF)

More announcements from Orchid Pharma Ltd

All Orchid Pharma Ltd announcements